"Designing Growth Strategies is in our DNA"

Human Antithrombin Market Size, Share & Industry Analysis, By Application (Therapeutic and Research & Diagnostic), By Dosage Form (Lyophilized Powder and Liquid), By End User (Hospitals & Clinics, Pharmaceutical & Biotechnology Industry, and Research Institutes), and Regional Forecast, 2025-2032

Last Updated: December 22, 2025 | Format: PDF | Report ID: FBI113611

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Market Scope
    2. Market Segmentation
    3. Market Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Key Cardiovascolar Diseases, By Key Countries
    2. Regolatory Scenario, By Key Countries
    3. Key Industry Developments (Mergers, Acquisitions, Partnerships, Approvals, Launches etc.)
  5. Global Human Antithrombin Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Application
      1. Therapeutic
      2. Research & Diagnostic
    2. Market Analysis, Insights and Forecast – By Dosage Form
      1. Lyophilized Powder
      2. Liquid
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Clinics
      2. Pharmaceutical & Biotechnology Industry
      3. Research Institutes
    4. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Rest of the World 
  6. North America Human Antithrombin Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Application
      1. Therapeutic
      2. Research & Diagnostic
    2. Market Analysis, Insights and Forecast – By Dosage Form
      1. Lyophilized Powder
      2. Liquid
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Clinics
      2. Pharmaceutical & Biotechnology Industry
      3. Research Institutes
    4. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Human Antithrombin Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Application
      1. Therapeutic
      2. Research & Diagnostic
    2. Market Analysis, Insights and Forecast – By Dosage Form
      1. Lyophilized Powder
      2. Liquid
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Clinics
      2. Pharmaceutical & Biotechnology Industry
      3. Research Institutes
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Germany
      2. UK
      3. France
      4. Italy
      5. Spain
      6. Scandinavia
      7. Rest of Europe 
  8. Asia Pacific Human Antithrombin Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Application
      1. Therapeutic
      2. Research & Diagnostic
    2. Market Analysis, Insights and Forecast – By Dosage Form
      1. Lyophilized Powder
      2. Liquid
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Clinics
      2. Pharmaceutical & Biotechnology Industry
      3. Research Institutes
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. South Korea
      6. Southeast Asia
      7. Rest of Asia Pacific
  9. Rest of World Human Antithrombin Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Application
      1. Therapeutic
      2. Research & Diagnostic
    2. Market Analysis, Insights and Forecast – By Dosage Form
      1. Lyophilized Powder
      2. Liquid
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Clinics
      2. Pharmaceutical & Biotechnology Industry
      3. Research Institutes 
  10. Competitive Analysis
    1. Global Market Share Analysis (2024)
    2. Company Profiles
      1. CSL
        1. Overview
        2. Products
        3. Financials (Based on Availability)
        4. Recent Developments
        5. Strategies
        6. SWOT,Etc.
      2. Octapharma AG
        1. Overview
        2. Products
        3. Financials (Based on Availability)
        4. Recent Developments
        5. Strategies
        6. SWOT,Etc.
      3. Takeda Pharmaceutical Company Limited
        1. Overview
        2. Products
        3. Financials (Based on Availability)
        4. Recent Developments
        5. Strategies
        6. SWOT,Etc.
      4. Grifols, S.A.
        1. Overview
        2. Products
        3. Financials (Based on Availability)
        4. Recent Developments
        5. Strategies
        6. SWOT,Etc.
      5. Medix Biochemica
        1. Overview
        2. Products
        3. Financials (Based on Availability)
        4. Recent Developments
        5. Strategies
        6. SWOT,Etc.
      6. Kedrion S.p.A.
        1. Overview
        2. Products
        3. Financials (Based on Availability)
        4. Recent Developments
        5. Strategies
        6. SWOT,Etc.
      7. Scripps Laboratories
        1. Overview
        2. Products
        3. Financials (Based on Availability)
        4. Recent Developments
        5. Strategies
        6. SWOT,Etc.
  1. Introduction
    1. Market Scope
    2. Market Segmentation
    3. Market Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Key Cardiovascolar Diseases, By Key Countries
    2. Regolatory Scenario, By Key Countries
    3. Key Industry Developments (Mergers, Acquisitions, Partnerships, Approvals, Launches etc.)
  5. Global Human Antithrombin Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Application
      1. Therapeutic
      2. Research & Diagnostic
    2. Market Analysis, Insights and Forecast – By Dosage Form
      1. Lyophilized Powder
      2. Liquid
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Clinics
      2. Pharmaceutical & Biotechnology Industry
      3. Research Institutes
    4. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Rest of the World 
  6. North America Human Antithrombin Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Application
      1. Therapeutic
      2. Research & Diagnostic
    2. Market Analysis, Insights and Forecast – By Dosage Form
      1. Lyophilized Powder
      2. Liquid
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Clinics
      2. Pharmaceutical & Biotechnology Industry
      3. Research Institutes
    4. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Human Antithrombin Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Application
      1. Therapeutic
      2. Research & Diagnostic
    2. Market Analysis, Insights and Forecast – By Dosage Form
      1. Lyophilized Powder
      2. Liquid
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Clinics
      2. Pharmaceutical & Biotechnology Industry
      3. Research Institutes
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Germany
      2. UK
      3. France
      4. Italy
      5. Spain
      6. Scandinavia
      7. Rest of Europe 
  8. Asia Pacific Human Antithrombin Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Application
      1. Therapeutic
      2. Research & Diagnostic
    2. Market Analysis, Insights and Forecast – By Dosage Form
      1. Lyophilized Powder
      2. Liquid
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Clinics
      2. Pharmaceutical & Biotechnology Industry
      3. Research Institutes
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. South Korea
      6. Southeast Asia
      7. Rest of Asia Pacific
  9. Rest of World Human Antithrombin Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Application
      1. Therapeutic
      2. Research & Diagnostic
    2. Market Analysis, Insights and Forecast – By Dosage Form
      1. Lyophilized Powder
      2. Liquid
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Clinics
      2. Pharmaceutical & Biotechnology Industry
      3. Research Institutes 
  10. Competitive Analysis
    1. Global Market Share Analysis (2024)
    2. Company Profiles
      1. CSL
        1. Overview
        2. Products
        3. Financials (Based on Availability)
        4. Recent Developments
        5. Strategies
        6. SWOT,Etc.
      2. Octapharma AG
        1. Overview
        2. Products
        3. Financials (Based on Availability)
        4. Recent Developments
        5. Strategies
        6. SWOT,Etc.
      3. Takeda Pharmaceutical Company Limited
        1. Overview
        2. Products
        3. Financials (Based on Availability)
        4. Recent Developments
        5. Strategies
        6. SWOT,Etc.
      4. Grifols, S.A.
        1. Overview
        2. Products
        3. Financials (Based on Availability)
        4. Recent Developments
        5. Strategies
        6. SWOT,Etc.
      5. Medix Biochemica
        1. Overview
        2. Products
        3. Financials (Based on Availability)
        4. Recent Developments
        5. Strategies
        6. SWOT,Etc.
      6. Kedrion S.p.A.
        1. Overview
        2. Products
        3. Financials (Based on Availability)
        4. Recent Developments
        5. Strategies
        6. SWOT,Etc.
      7. Scripps Laboratories
        1. Overview
        2. Products
        3. Financials (Based on Availability)
        4. Recent Developments
        5. Strategies
        6. SWOT,Etc.
Read Less

Figure 1:  Global Human Antithrombin Market Revenue Breakdown (USD million, %) by Region, 2024 & 2032

Figure 2:  Global Human Antithrombin Market Value Share (%), by Application, 2024 & 2032

Figure 3:  Global Human Antithrombin Market Value Share (%), by Dosage Form, 2024 & 2032

Figure 4:  Global Human Antithrombin Market Value Share (%), by End User, 2024 & 2032

Figure 5:  Global Human Antithrombin Market Value (USD million), by Region, 2024 & 2032

Figure 6:  North America Human Antithrombin Market Value (USD million), by Application, 2024 & 2032

Figure 7:  North America Human Antithrombin Market Value Share (%), by Application, 2024

Figure 8:  North America Human Antithrombin Market Value (USD million), by Dosage Form, 2024 & 2032

Figure 9:  North America Human Antithrombin Market Value Share (%), by Dosage Form, 2024

Figure 10:  North America Human Antithrombin Market Value (USD million), by End User, 2024 & 2032

Figure 11:  North America Human Antithrombin Market Value Share (%), by End User, 2024

Figure 12:  North America Human Antithrombin Market Value (USD million), By Country, 2024 & 2032

Figure 13:  North America Human Antithrombin Market Value Share (%), By Country, 2024

Figure 14:  Europe Human Antithrombin Market Value (USD million), by Application, 2024 & 2032

Figure 15:  Europe Human Antithrombin Market Value Share (%), by Application, 2024

Figure 16:  Europe Human Antithrombin Market Value (USD million), by Dosage Form, 2024 & 2032

Figure 17:  Europe Human Antithrombin Market Value Share (%), by Dosage Form, 2024

Figure 18:  Europe Human Antithrombin Market Value (USD million), by End User, 2024 & 2032

Figure 20:  Europe Human Antithrombin Market Value Share (%), by End User, 2024

Figure 21:  Europe Human Antithrombin Market Value (USD million), By Country/ Sub-region, 2024 & 2032

Figure 22:  Europe Human Antithrombin Market Value Share (%), By Country/ Sub-region, 2024

Figure 23:  Asia Pacific Human Antithrombin Market Value (USD million), by Application, 2024 & 2032

Figure 24:  Asia Pacific Human Antithrombin Market Value Share (%), by Application, 2024

Figure 25:  Asia Pacific Human Antithrombin Market Value (USD million), by Dosage Form, 2024 & 2032

Figure 26:  Asia Pacific Human Antithrombin Market Value Share (%), by Dosage Form, 2024

Figure 27:  Asia Pacific Human Antithrombin Market Value (USD million), by End User, 2024 & 2032

Figure 28:  Asia Pacific Human Antithrombin Market Value Share (%), by End User, 2024

Figure 29:  Asia Pacific Human Antithrombin Market Value (USD million), By Country/ Sub-region, 2024 & 2032

Figure 30:  Asia Pacific Human Antithrombin Market Value Share (%), By Country/ Sub-region, 2024

Figure 31:  Rest of the World Human Antithrombin Market Value (USD million), by Application, 2024 & 2032

Figure 32:  Rest of the World Human Antithrombin Market Value Share (%), by Application, 2024

Figure 33:  Rest of the World Human Antithrombin Market Value (USD million), by Dosage Form, 2024 & 2032

Figure 34:  Rest of the World Human Antithrombin Market Value Share (%), by Dosage Form, 2024

Figure 35:  Rest of the World Human Antithrombin Market Value (USD million), by End User, 2024 & 2032

Figure 36:  Rest of the World Human Antithrombin Market Value Share (%), by End User, 2024

Figure 37:  Global Human Antithrombin Market Share (%), By Company, 2024

Table 1:  Global Human Antithrombin Market Revenue (USD million) Forecast, by Application, 2019–2032

Table 2:  Global Human Antithrombin Market Revenue (USD million) Forecast, by Dosage Form, 2019–2032

Table 3:  Global Human Antithrombin Market Revenue (USD million) Forecast, by End User, 2019–2032

Table 4:  Global Human Antithrombin Market Revenue (USD million) Forecast, by Region, 2019-2032

Table 5:  North America Human Antithrombin Market Revenue (USD million) Forecast, by Application, 2019-2032

Table 6:  North America Human Antithrombin Market Revenue (USD million) Forecast, by Dosage Form, 2019-2032

Table 7:  North America Human Antithrombin Market Revenue (USD million) Forecast, by End User, 2019-2032

Table 8:  North America Human Antithrombin Market Revenue (USD million) Forecast, By Country, 2019-2032

Table 9:  Europe Human Antithrombin Market Revenue (USD million) Forecast, by Application, 2019-2032

Table 10:  Europe Human Antithrombin Market Revenue (USD million) Forecast, by Dosage Form, 2019-2032

Table 11:  Europe Human Antithrombin Market Revenue (USD million) Forecast, by End User, 2019-2032

Table 12:  Europe Human Antithrombin Market Revenue (USD million) Forecast, By Country/ Sub-region, 2019-2032

Table 13: Asia Pacific Human Antithrombin Market Revenue (USD million) Forecast, by Application, 2019-2032

Table 14: Asia Pacific Human Antithrombin Market Revenue (USD million) Forecast, by Dosage Form, 2019-2032

Table 15:  Asia Pacific Human Antithrombin Market Revenue (USD million) Forecast, by End User, 2019-2032

Table 16:  Asia Pacific Human Antithrombin Market Revenue (USD million) Forecast, By Country/ Sub-region, 2019-2032

Table 17: Rest of the World Human Antithrombin Market Revenue (USD million) Forecast, by Application, 2019-2032

Table 18: Rest of the World Human Antithrombin Market Revenue (USD million) Forecast, by Dosage Form, 2019-2032

Table 19: Rest of the World Human Antithrombin Market Revenue (USD million) Forecast, by End User, 2019-2032

Human Antithrombin Market
  • 2019-2032
  • 2024
  • 2019-2023
  • 100
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports